As per the claim by the researchers Ivabradine, reduces Diastolic Dysfunction and Cardiac Fibrosis. The study was conducted on rabbits given a standard diet, a cholesterol-enriched diet or a cholesterol-enriched
diet with ivabradine. Researchers found that apart from improving the
myocardial performance index, ivabradine greatly improved left
ventricular diastolic dysfunction in animals receiving a cholesterol-enriched diet. Ivabradine also reduced fibrosis of the heart chambers adds the researchers.
According
to Dr. Jean-Claude Tardif, Director of the MHI Research Centre and
professor of medicine at the Universit- de Montr-al,
"The effectiveness of ivabradine in treating angina pectoris is now well known. However, few treatments are available to patients with diastolic heart failure. The beneficial effects of ivabradine demonstrated in laboratory suggest that this course of treatment should be further investigated." Clinical studies with subjects are expected to follow..........http://www.icm-mhi.org/files//pdf/Communique-EN-2011/press_release_Ivabradine.pdf
